These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11466957

  • 1. Riluzole.
    Gelinas DF.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Dec; 1 Suppl 4():3-4. PubMed ID: 11466957
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG, Mitchell JD, Lyon M, Moore DH.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [Abstract] [Full Text] [Related]

  • 4. [Riluzole treatment in amyotrophic lateral sclerosis].
    Wokke JH.
    Ned Tijdschr Geneeskd; 1996 Nov 16; 140(46):2265-8. PubMed ID: 8984377
    [No Abstract] [Full Text] [Related]

  • 5. [Adverse efects of riluzole (Rilutek) in the treatment of amyotrophic lateral sclerosis].
    Roch-Torreilles I, Camu W, Hillaire-Buys D.
    Therapie; 2000 Nov 16; 55(2):303-12. PubMed ID: 10967703
    [Abstract] [Full Text] [Related]

  • 6. Slowing down ALS--is this good or bad?
    Munsat TL.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2001 Mar 16; 2 Suppl 1():S19-22. PubMed ID: 11465919
    [Abstract] [Full Text] [Related]

  • 7. Rilutek (Riluzole) may extend survival in amyotrophic lateral sclerosis.
    J Neurosci Nurs; 1996 Aug 16; 28(4):275. PubMed ID: 8880606
    [No Abstract] [Full Text] [Related]

  • 8. Plasma glutamate and glycine levels in patients with amyotrophic lateral sclerosis: the effect of riluzole treatment.
    Andreadou E, Kapaki E, Kokotis P, Paraskevas GP, Katsaros N, Libitaki G, Zis V, Sfagos C, Vassilopoulos D.
    Clin Neurol Neurosurg; 2008 Mar 16; 110(3):222-6. PubMed ID: 18055102
    [Abstract] [Full Text] [Related]

  • 9. Preface: the state of the science of all motor neuron diseases.
    Weiss MD, Carter GT.
    Phys Med Rehabil Clin N Am; 2008 Aug 16; 19(3):xix-xx. PubMed ID: 18625405
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Disease-modifying drug therapies.
    Brooks BR, Sanjak M.
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep 16; 5 Suppl 1():68-75. PubMed ID: 15512878
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Neuroprotective therapy for amyotrophic lateral sclerosis (ALS)].
    Yanagisawa N, Shindo M.
    Rinsho Shinkeigaku; 1996 Dec 16; 36(12):1329-30. PubMed ID: 9128396
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.